A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
Clinical trial NCT02596503 · COMPLETED
Trial details
- NCT number
- NCT02596503
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-21
- Primary completion
- 2019-04-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.